MediciNova Announces Two Abstracts regarding MN-001 (tipelukast) and MN-002 Accepted for Presentation at the 92nd EAS 2024 Congress, the Annual Meeting of the European Atherosclerosis Society

Source: Nasdaq GlobeNewswire / 20 Mar 2024 19:00:00   America/New_York